Therapeutic efficacy of DNA encoding IFN-a1 against corneal HSV-1 infection

References

• Whitley RJ, Roizman B. Herpes simplex viruses. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical Virology. New York, NY: Churchill Livingstone; 1997;375–410.
   Google Scholar
• Honess RW, Roizman B. Regulation of herpesvirus macromolocular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol. 1974;14:8–19.
   Google Scholar
• Honess RW, Roizman B. Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypep-tides. Proc Natl Acad Sci USA. 1975;72:1276–1280.
   PubMed Web of Science ®Google Scholar
• Liu T, Tang Q, Hendricks RL. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol. 1996;70: 264–271.
   Google Scholar
• Tumpey TM, Chen SH, Oakes JE, Lausch RN. Neutro-phil-mediated suppression of virus replication after herpes simplex virus type linfection of the murine cornea. J Virol. 1996;70: 898–904.
   PubMed Web of Science ®Google Scholar
• Brandt CR, Salkowski CA. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1. Invest Ophthalmol Vis Sci. 1992;33:113–120.
   PubMed Web of Science ®Google Scholar
• Halford WP, Gebhardt BM, Can DJJ. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol. 1996;157: 3542–3549.
   Google Scholar
• Su Y-H., Yan X-T, Oakes JE, Lausch RN. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infec-tion. J Virol. 1996;70:1277–1281.
   PubMed Web of Science ®Google Scholar
• Babu JS, Kanangat S, Rouse BT. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J Immunol. 1995;154:4822–4829.
   Google Scholar
• Niemialtowski MG, Rouse BT. Predominance of Thl cells in ocular tissues during herpetic stromal keratitis. J Immunol. 1992;149:3035–3039.
   PubMed Web of Science ®Google Scholar
• Hendricks RL, Janowicz M, Tumpey TM. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J Immunol. 1992;148: 2522–2529.
   Google Scholar
• Shimeld C, Whiteland JL, Williams NA, Easty DL, Hill T. Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J Gen Virol. 1997;78: 3317–3325.
   Google Scholar
• Baron SB, Tyring SK, Fleischmann WR, et al. The interferons: mechanisms of action and clinical applica-tions. JAMA. 1991;266:1375–1383.
   PubMed Web of Science ®Google Scholar
• Hendricks RL, Weber PC, Taylor JL. Endogenously produced interferon a protects mice from herpes sim-plex virus type 1 corneal disease. J Gen Virol. 1991; 72:1601–1610.
   Google Scholar
• Halford WP, Veress LA, Gebhardt BM, Can DJJ. Im-munization with HSV-1 antigen rapidly protects against HSV-1-induced encephalitis and is IFN-y independent. J Interferon Cytokine Res. 1998;18:151–158.
   PubMed Web of Science ®Google Scholar
• Can DJJ, Veress LA, Noisakran S, Campbell IL. Astro-cytes targeted expression of interferon-al protects mice from acute ocular herpes simplex virus type 1 infection. J Immunol. 1998;161:4859–4865.
   PubMed Web of Science ®Google Scholar
• Yeow W, Lawson CM, Beilharz MW. Antiviral activi-ties of individual murine IFN-a subtypes in vivo: intra-muscular injection of IFN expression constructs reduces cytomegalovirus replication. J Immunol. 1998;160: 2932–2939.
   Google Scholar
• Noisakran S, Campbell IL, Can DJJ. Ectopic expression of DNA encoding IFN-al in the cornea protects mice from herpes simplex virus type 1-induced encephalitis. J Immunol. 1999;162: 4184–4190.
   Google Scholar
• Sambrook JE, Fritsch F, Maniatis T. In: Nolan C, ed. Molecular Cloning: Laboratory Manual. Vol. 1. Plain-view, NY: Cold Spring Harbor Laboratory Press; 1989: 1.42–1.45.
   Google Scholar
• Welsh RM, Sen GC. Nonspecific host responses to viral infections. In: Nathanson N, ed. Viral Pathogenesis. Philadelphia, PA: Lippincott-Raven Publishers; 1997: 109–141
   Google Scholar
• Foster GR. Interferons in host defense. Semin Liver Dis. 1997;17:287–295.
   PubMed Web of Science ®Google Scholar
• Mittnacht S, Straub P, Kirchner H, Jacobsen H. Inter-feron inhibits onset of herpes simplex virus immediate-early transcription. Virology 1988;164:201–210.
   PubMed Web of Science ®Google Scholar
• Straub P, Domke, Kirchner H, Jacobsen H, Panet A. Synthesis of herpes simplex virus proteins and nucleic acids in interferon-treated macrophages. Virology 1986; 150:411–418.
   Google Scholar
• Munoz A, Carrasco L. Formation of non-infective her-pesvirus particles in cultured cells treated with human interferon. J Gen Virol. 1984;65:1069–1078.
   PubMed Web of Science ®Google Scholar
• Sundmacher R, Neumann-Haefelin D, Manthey KF, Muller 0. Interferon in treatment of dendritic keratitis in humans: A preliminary report. J Infect Dis. 1976;133: A160–A164.
   Google Scholar
• Kaufman HE, Meyer RF, Laibson PR, Waltman SR, Nesburn AB, Shuster JJ. Human leukocyte interferon for the prevention of recurrences of herpetic keratitis. J In-fect Dis. 1976;133:A165–A168.
   Google Scholar
• Sacks WR, Greene CC, Aschman DP, Schaffer PA. Herpes simplex type 1 ICP27 is an essential regulatory protein. J Viro/.1985;55:796–805.
   Web of Science ®Google Scholar
• Uprichard SL, Knipe DM. Herpes simplex ICP27 mu-tant viruses exhibit reduced expression of specific DNA replication genes. J Virol. 199670:1969-1980.
   PubMed Web of Science ®Google Scholar
• Soliman TM, Sandri-Goldin RM, Silverstein SJ. Shut-tling of the herpes simplex virus 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression of late proteins. J Virol. 1997;71:9188–9197.
   PubMed Web of Science ®Google Scholar
• Mears WE, Rice SA. The herpes simplex virus immedi-ate-early protein ICP27 shuttles between nucleus and cytoplasm. Virology. 1998;242:128–137.
   PubMed Web of Science ®Google Scholar
• Hardwicke MA, Sandri-Goldin RM. The herpes simplex virus regulatory protein ICP27 contributes to he de-crease in cellular mRNA levels during infection. J Virol. 1994;68:4797–4810.
   PubMed Web of Science ®Google Scholar
• McLauchlan J, Phelan A, Loney C, Sandri-Goldin RM, Clements JB. Herpes simplex virus 1E63 acts at the posttranscriptional levels to stimulate viral mRNA 3' processing. J Virol. 1992;70: 6939–6945.
   Google Scholar
• Sandri-Goldin RM, Mendoza GE. A herpes virus regu-latory protein appears to act posttranscriptionally by affecting mRNA processing. Genes Dev. 1992;6:848–863.
   Google Scholar
• Hardy RW, Sandri-Goldin RM. Herpes simplex virus inhibits host cell splicing and the regulatory protein ICP27 is required for this effect. J Virol. 1994;68:7790–7799.
   PubMed Web of Science ®Google Scholar
• McGregor F, Phelan A, Dunlop J, Clements JB. Regu-lation of herpes simplex virus type 1 poly(A) site usage and the action of the immediate-early protein 1E63 in the early-late switch. J Virol. 199670:1931-1940.
   PubMed Web of Science ®Google Scholar
• Phelan A, Dunlop J, Clements JB. Herpes simplex virus type 1 protein 1E63 affects the nuclear export of virus intron-containing transcripts. J Virol. 1996;70: 5255–5265.
   Google Scholar
• Aubert M, Blaho JA. The herpes simplex virus 1 regu-latory protein ICP27 is required for the prevention of apoptosis in infected human cells. J Virol. 1999;73: 2803–2813.
   PubMed Web of Science ®Google Scholar
• Gordon YJ, Gilgen DM, Becker Y. HSV-1 thymidine kinase promotes virulence and latency in the mouse. Invest Ophthalmol Vis Sci. 1983;24: 599–602.
   Google Scholar
• Gordon Y, Gilden DH, Shtram Y, et al. A low thymi-dine kinase-producing mutant of herpes simplex virus type causes latent trigeminal ganglia infections in mice. Arch Virol. 1983;76:39–49.
   PubMed Web of Science ®Google Scholar
• Ben-Hur T, Hadar J, Shtram Y, Gilgen DH, Becker Y. Neurovirulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression. Arch Virol. 1983;78: 303–308.
   Google Scholar
• Noisakran S, Campbell IL, Can DJJ. IFN-al plasmid construct affords protection against HSV-1 infection in transfected L929 fibroblasts. J Interferon Cytokine Res. 2000;20: 107–115.
   Google Scholar
• See DM, Khemka P, Sahl L, Bui T, Tilles JG. The role of natural killer cells in viral infection. Scand J Immunol. 1997;46:217–224.
   PubMed Web of Science ®Google Scholar
• Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189–220.
   Google Scholar
• Klinman DM, Yi A-K, Beaucage SL, Conover J, Krieg AM. CpG motifs present in bacterial DNA rapidly in-duce lymphocytes to secrete interieukin 6, interieukin-12, and interferon y. Proc Natl Acad Sci USA. 1996;93: 2879–2883.
   Google Scholar
• Pisetsky DS. The immunologic properties of DNA. J Immunol. 1996;156:421–423.
   PubMed Web of Science ®Google Scholar
• Tighe H, Con M, Roman M, Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 19:89–97.
   Google Scholar
• Feigner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Feigner PL. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem. 1994;269: 2550–2561.
   Google Scholar
• Dow SW, Fradkin LG, Liggitt, DH, Willson AP, Heath TD, Potter TA. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor ac-tivity when administered intravenously. J Immunol. 1999; 163;1552–1561.
   Google Scholar
• Pisetsky DS, Reich CF III. The influence of lipofectin on the in vitro stimulation of murine spleen cells by bacterial DNA and plasmid DNA vectors. J Interferon Cytokine Res. 1999;19:1219–1226.
   PubMed Web of Science ®Google Scholar